HKSE - Delayed Quote HKD

XtalPi Holdings Limited (2228.HK)

4.630

0.000

(0.00%)

As of 1:27:40 PM GMT+8. Market Open.

XtalPi and Kula Bio Forge Multi-Million USD Collaborative R&D Agreement to Advance AI-Driven Microbial Fertilizers in China and the Middle East

XtalPi (2228.HK) today announced the official signing of a strategic R&D collaboration agreement with U.S.-based Kula Bio in Boston. This partnership initiates a joint research initiative worth multi-million USD, focused on developing the next generation of microbial organic fertilizers to provide breakthrough solutions for agriculture in arid and desert regions. By integrating artificial intelligence (AI), microbial technology, and automation, the collaboration aims to enhance agricultural prod

PR Newswire last month

2228.HK
0.00%
UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform

UCB, a global biopharmaceutical company, and XtalPi, a global leader in AI drug discovery, today announced a license agreement on XtalFold™, a biologics AI platform developed by Ailux Biologics, a division of XtalPi.

PR Newswire 3 months ago

2228.HK
0.00%
XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific

XtalPi (2228.HK) has announced a strategic partnership with Indonesia's powerhouse, led by one of its prominent business pillar Sinar Mas Multiartha. This landmark collaboration is set to transform the future of artificial intelligence (AI) and robotics across the Asia-Pacific region. By establishing an ambitious joint venture, the alliance will integrate XtalPi's cutting-edge AI and robotics research capabilities with Sinar Mas Group's extensive industry reach, setting the stage for a commercia

PR Newswire 6 months ago

2228.HK
0.00%
Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform

XtalPi, a global leader in AI drug discovery, announced today a license agreement between Ailux Biologics, a division of XtalPi Inc., and Janssen Biotech, Inc.,(Janssen) a Johnson & Johnson company, on one of its proprietary biologics AI platforms. Under the agreement, Ailux Biologics grants Janssen and its affiliates a non-exclusive license to leverage its XtalFold™ platform for the discovery and engineering of biologics. XtalFold™ is a proprietary AI-based software suite that provides rapid an

PR Newswire 6 months ago

2228.HK
0.00%
XtalPi Launches Computational Chemistry Software for Drug Discovery: XMolGen and XFEP

Today, XtalPi announced the official launch of XFEP and XMolGen, two proprietary software products designed to accelerate and enhance the efficiency of drug discovery. Upon this launch, XtalPi will offer commercial licenses with flexible terms for industrial and academic scientists to use the software based on their research goals. With user-friendly interfaces, these platforms are seamlessly integrated within a shared suite to enable streamlined drug discovery workflows.

PR Newswire 7 months ago

2228.HK
0.00%

Performance Overview

Return	2228.HK	HANG SENG INDEX (^HSI)
YTD	-22.58%	+15.41%
1-Year	-14.10%	+22.08%
3-Year	-14.10%	+19.46%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

XtalPi Holdings Limited (2228.HK)

XtalPi and Kula Bio Forge Multi-Million USD Collaborative R&D Agreement to Advance AI-Driven Microbial Fertilizers in China and the Middle East

UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform

XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific

Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform

XtalPi Launches Computational Chemistry Software for Drug Discovery: XMolGen and XFEP

Performance Overview